The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorThe Chaim Sheba Medical Center
About this trial
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Eligibility criteria
Qualifiers
chromosomal deletion proven by FISH examination
Disqualifiers
None
Trial design
Treatments tested in this trial
- methylphenidate, fluoxetin, risperidone
Treatment groups
400 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov